<DOC>
	<DOCNO>NCT03080077</DOCNO>
	<brief_summary>This prospective , randomize study conduct evaluate safety effectiveness corneal cross-linking ( CXL ) patient keratoconus post-refractive ectasia ( post-LASIK PRK ) utilize two technique : `` standard '' Epi-Off technique Epi-On technique utilizes iontophoresis ( I-CXL ) deliver riboflavin cornea without need removal corneal epithelium . Patients randomize receive CXL treatment either Epi-On Epi-Off technique .</brief_summary>
	<brief_title>Safety Effectiveness Corneal Crosslinking ( CXL ) : Keratoconus Post-Refractive Ectasia</brief_title>
	<detailed_description />
	<mesh_term>Keratoconus</mesh_term>
	<mesh_term>Dilatation , Pathologic</mesh_term>
	<criteria>1 . 18 year age old 2 . Understand sign write IRBapproved inform consent 3 . Willingness ability comply schedule followup visit 4 . Having diagnosis keratoconus postrefractive corneal ectasia ( postLASIK PRK ) 5 . Presence central inferior steepen Pentacam map 6 . Axial topography consistent keratoconus postrefractive corneal ectasia ( postLASIK PRK ) 7 . Presence one slit lamp finding associate keratoconus , : 1 . Scissoring retinoscopic reflex 2 . Fleischer ring 3 . Vogt striae 4 . Corneal thin 5 . Corneal scar 8 . BSCVA 20/20 bad ( &lt; 58 letter ETDRS chart ) . 9 . Contact lens wearer : Removal contact lenses required period time prior first refraction : Contact Lens Type Minimum Discontinuation Time Soft 3 Days Soft Extended Wear 1 Week Soft Toric 2 Weeks Rigid gas permeable 2 Weeks Hybrid lens ( SynergEyes ; Rose K ; Clear Kone ) 2 Weeks Scleral Lenses 2 Weeks 1 . A history previous corneal surgery eye treat ( include previous CXL treatment ) . Eyes episodes hydrops scar hydrops may include long active inflammation 2 . Corneal pachymetry &lt; 400 micron thinnest point measure Pentacam 3 . Previous ocular condition ( refractive error ) eye ( ) treat may predispose eye future complication prevent possibility improve vision , example : 1 . History corneal disease ( e.g. , herpes simplex , herpes zoster keratitis , recurrent erosion syndrome , corneal melt , corneal dystrophy , etc . ) 2 . Clinically significant corneal scar treatment zone 4 . A history chemical injury delay epithelial healing eye ( ) treat 5 . Pregnancy ( include plan become pregnant ) lactation course study 6 . A known sensitivity study medication 7 . Nystagmus condition would prevent steady gaze crosslinking treatment diagnostic test 8 . A condition , investigator 's opinion , would interfere prolong epithelial heal 9 . Presence history condition finding , investigator 's opinion , make patient unsuitable candidate crosslinking study participation may confound outcome study 10 . Inability cooperate diagnostic test inability understand inform consent . 11 . Concurrent use systemic ( include inhale ) medication may impair heal , include limited : antimetabolite , isotretinoin ( Accutane® ) within 6 month treatment , amiodarone hydrochloride ( Cordarone® ) within 12 month treatment . NOTE : The use inhale systemic corticosteroid , whether chronic acute , deem adversely affect healing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>